Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia

P Vejchapipat1, A Theamboonlers, S Poomsawat

  • 1Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. pvejchap@yahoo.co.uk

Insights

Elevated serum transforming growth factor-beta1 (TGF-beta1) and epidermal growth factor (EGF) indicate a good therapeutic outcome in children with biliary atresia (BA). These growth factors were also positively correlated in BA patients.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Biomarker Discovery

Background:

  • Biliary atresia (BA) is a severe pediatric liver disease impacting hepatic repair.
  • Transforming growth factor-beta1 (TGF-beta1) and epidermal growth factor (EGF) are implicated in liver healing processes.

Purpose of the Study:

  • To investigate the association between serum TGF-beta1 and EGF levels and therapeutic outcomes in pediatric BA patients.
  • To explore the correlation between TGF-beta1 and EGF in the context of BA treatment success.

Main Methods:

  • Serum TGF-beta1 and EGF levels were quantified using ELISA in 67 postoperative BA patients and 10 healthy controls.
  • BA patients were stratified into good (jaundice-free) and poor (persistent jaundice) outcome groups for comparative analysis.
  • Clinical data and growth factor levels were compared; correlation analysis between TGF-beta1 and EGF was performed.

Main Results:

  • Serum TGF-beta1 levels were significantly higher in BA patients compared to controls (p=0.0362).
  • No significant difference in serum EGF was observed between BA patients and controls (p=0.744).
  • Patients with good BA outcomes exhibited significantly higher serum TGF-beta1 (p=0.002) and EGF (p=0.02) levels compared to those with poor outcomes.
  • A significant positive correlation was found between serum TGF-beta1 and serum EGF levels (r=0.3418, p=0.0046).

Conclusions:

  • Elevated serum TGF-beta1 and EGF levels are associated with favorable therapeutic outcomes in pediatric BA.
  • The positive correlation suggests a potential interplay between TGF-beta1 and EGF pathways in postoperative BA.
  • These findings highlight TGF-beta1 and EGF as potential biomarkers for assessing BA treatment efficacy.
Abstract

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...